NO965244D0 - Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling derav - Google Patents

Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling derav

Info

Publication number
NO965244D0
NO965244D0 NO965244A NO965244A NO965244D0 NO 965244 D0 NO965244 D0 NO 965244D0 NO 965244 A NO965244 A NO 965244A NO 965244 A NO965244 A NO 965244A NO 965244 D0 NO965244 D0 NO 965244D0
Authority
NO
Norway
Prior art keywords
hydrophobic active
pct
active substance
preparation
pharmaceutical composition
Prior art date
Application number
NO965244A
Other languages
English (en)
Other versions
NO965244L (no
NO314016B1 (no
Inventor
Gerhard Gergely
Original Assignee
Gerhard Gergely
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerhard Gergely filed Critical Gerhard Gergely
Publication of NO965244D0 publication Critical patent/NO965244D0/no
Publication of NO965244L publication Critical patent/NO965244L/no
Publication of NO314016B1 publication Critical patent/NO314016B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19965244A 1994-06-15 1996-12-09 Farmasöytisk preparat inneholdende en hydrofob aktiv substans og et brusesystem, og fremgangsmåte til fremstilling derav NO314016B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH01890/94A CH686865A5 (de) 1994-06-15 1994-06-15 Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.
PCT/EP1995/001904 WO1995034284A1 (de) 1994-06-15 1995-05-19 Pharmazeutische zubereitung mit einem hydrophoben wirkstoff und einem brausesystem, sowie verfahren zur herstellung der zubereitung

Publications (3)

Publication Number Publication Date
NO965244D0 true NO965244D0 (no) 1996-12-09
NO965244L NO965244L (no) 1997-02-13
NO314016B1 NO314016B1 (no) 2003-01-20

Family

ID=4221002

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19965244A NO314016B1 (no) 1994-06-15 1996-12-09 Farmasöytisk preparat inneholdende en hydrofob aktiv substans og et brusesystem, og fremgangsmåte til fremstilling derav

Country Status (26)

Country Link
US (1) US5834019A (no)
EP (1) EP0768868B1 (no)
JP (1) JPH10501535A (no)
KR (1) KR100367302B1 (no)
CN (1) CN1149071C (no)
AT (1) ATE204744T1 (no)
AU (1) AU684966B2 (no)
BR (1) BR9508002A (no)
CA (1) CA2191302C (no)
CH (1) CH686865A5 (no)
CO (1) CO4410175A1 (no)
CZ (1) CZ287807B6 (no)
DE (1) DE59509566D1 (no)
ES (1) ES2161901T3 (no)
HU (1) HU221680B1 (no)
IL (1) IL114144A (no)
MX (1) MX9606391A (no)
MY (1) MY113718A (no)
NO (1) NO314016B1 (no)
NZ (1) NZ288208A (no)
PE (1) PE42295A1 (no)
PL (1) PL180135B1 (no)
SK (1) SK281262B6 (no)
TW (1) TW457097B (no)
WO (1) WO1995034284A1 (no)
ZA (1) ZA954932B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE220543T1 (de) * 1996-04-23 2002-08-15 Janssen Pharmaceutica Nv Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid
EP0803251B1 (en) * 1996-04-23 2002-07-17 Janssen Pharmaceutica N.V. Immediate release pH-independent solid dosage form of cisapride
JP2002504107A (ja) * 1997-06-11 2002-02-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ （＋）−または（−）−シサプリドの即時放出性ｐＨ非依存的固形投薬剤形
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
CA2440935A1 (en) * 2001-03-13 2002-09-19 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
US20030157170A1 (en) * 2001-03-13 2003-08-21 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
EP1800670A1 (en) * 2001-04-20 2007-06-27 The University of British Columbia Micellar drug delivery systems for hydrophobic drugs
AU2002333098B2 (en) * 2001-10-19 2006-03-16 Isotechnika Pharma Inc. Novel cyclosporin analog microemulsion preconcentrates
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
CN100381123C (zh) * 2005-01-12 2008-04-16 南京亿华药业有限公司 一种氯雷他定颗粒剂及其制法
CN101897732B (zh) * 2009-05-27 2013-01-30 北京因科瑞斯医药科技有限公司 一种中药泡腾片剂及其制备方法
CN106236713B (zh) * 2016-08-30 2018-11-09 林州中农颖泰生物肽有限公司 一种七清败毒泡腾颗粒及其制备方法
CN107296800A (zh) * 2017-06-01 2017-10-27 江苏黄河药业股份有限公司 一种氯雷他定泡腾片及其制备方法
CN112741841A (zh) * 2019-10-29 2021-05-04 湖北真奥医药研究院有限公司 三维钙自乳化泡腾剂组合物及其制剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106977B2 (ja) * 1984-12-14 1995-11-15 ゲルゲリイ、ゲルハルト 疎水性又は難溶性物質の粒子の親水化の方法
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs

Also Published As

Publication number Publication date
HU9603452D0 (en) 1997-02-28
TW457097B (en) 2001-10-01
CZ287807B6 (en) 2001-02-14
CN1151693A (zh) 1997-06-11
DE59509566D1 (de) 2001-10-04
PL317856A1 (en) 1997-04-28
HU221680B1 (hu) 2002-12-28
EP0768868B1 (de) 2001-08-29
CN1149071C (zh) 2004-05-12
SK281262B6 (sk) 2001-01-18
US5834019A (en) 1998-11-10
ES2161901T3 (es) 2001-12-16
AU684966B2 (en) 1998-01-08
JPH10501535A (ja) 1998-02-10
IL114144A (en) 1999-07-14
CH686865A5 (de) 1996-07-31
NZ288208A (en) 1998-08-26
ATE204744T1 (de) 2001-09-15
NO965244L (no) 1997-02-13
WO1995034284A1 (de) 1995-12-21
KR100367302B1 (ko) 2003-04-16
CZ367296A3 (en) 1997-04-16
KR970703131A (ko) 1997-07-03
IL114144A0 (en) 1995-10-31
SK159396A3 (en) 1997-08-06
CO4410175A1 (es) 1997-01-09
AU2749795A (en) 1996-01-05
CA2191302C (en) 2010-08-10
BR9508002A (pt) 2000-05-30
CA2191302A1 (en) 1995-12-21
HUT75674A (en) 1997-05-28
MX9606391A (es) 1997-07-31
EP0768868A1 (de) 1997-04-23
PE42295A1 (es) 1995-12-28
NO314016B1 (no) 2003-01-20
ZA954932B (en) 1996-02-07
PL180135B1 (pl) 2000-12-29
MY113718A (en) 2002-05-31

Similar Documents

Publication Publication Date Title
NO965244D0 (no) Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling derav
ATE188961T1 (de) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1- olverbindungen als pharmazeutische wirkstoffe
ATE183495T1 (de) 6-dimethylaminomethyl-1-phenyl-cyclo- hexanverbindungen als pharmazeutische wirkstoffe
PT760649E (pt) Formulacoes a base de propionato de fluticasona
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
DK0993830T3 (da) Nye stabiliserede galeniske formuleringer indeholdende en syrelabil benzimidazolforbindselse og fremgangsmåde til fremstilling heraf
BR9503386A (pt) Formulaçao farmacêutica comprimido dispersivel e processo para a fabricaçao de comprimidos dispersíveis contendo cloridrato de fluoxetina
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
FR2771291B1 (fr) Spheroides, procede de preparation et compositions pharmaceutiques
AU5651696A (en) Substituted 1-phenyl-3-pyrazolecarboxamides active on nurotensin receptors, their preparation and pharmaceutical compositions containing them
FR2707882B1 (fr) Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant.
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
MX9603607A (es) Matriz insecticida y su proceso de preparacion.
ES2178154T3 (es) Proceso de preparacion de formas solidas de dosificacion farmaceutica.
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
NO20005332L (no) 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding
BR9404225A (pt) Formulação de substância ativa, aplicação, composições, medicamentos e processo para a preparação das formulações
MA23663A1 (fr) Procede de preparation de formulations pharmaceutiques
SE8302580D0 (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
BR9508021A (pt) Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico
HRP940315A2 (en) Process for the preparation of pharmaceutical compositions containinbg active ingredient
AU7623496A (en) Stable mixtures of incompatible active ingredients for plant protection
NO980384L (no) Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler
NO307460B1 (no) Optiske aktive forbindelser, fremgangsmõte for fremstilling derav, farmasøytisk blanding og anvendelse derav
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance